国际医药卫生导报2014，Vol.20Issue(13)：1957-1959,3.DOI:10.3760/cma.j.issn.1007-1245.2014.13.044
布拉氏酵母菌治疗新生儿黄疸的临床研究
Clinical study of Saccharomyces boulardii in the treatment of neonatal jaundice
摘要
Abstract
Objective To investigate the effect of Saccharomyces boulardii in the treatment of neonatal jaundice.Methods 108 neonatal jaundice patients were randomly assigned to two groups.The control group received conventional treatment while the experimental group received conventional treatment,plus Saccharomyces boulardii powder.Serum bilirubin levels of both groups were detected before and after their treatments,thus to study the effect of Saccharomyces boulardii.Results After a 3-day treatment,the control group had a Serum Bilirubin level of (150.5 ± 40.6) μ mol/L while the experimental group got a level of (127.8 ± 48.5) μ mol/L.The difference was statistically significant at(P ＜ 0.05).After 5 days' treatment,the Bilirubin levels of the control group were at (66 ± 32.5) μ mol/L and those of the experimental group were at (42 ± 26.2) μ mol/L.The difference between both groups was statistically significant at (P ＜ 0.01).An everage Icteric subsidise period for the control group was(5.8 ± 1.4) d while that for the experimental group was (4.1 ± 1.1) d.The difference was statistically significant at(P ＜ 0.05).So Bilirubin levels of the experimental group reduced quicker and better.Conclusion Saccharomyces boulardii has auxo-action to the excretion of bilirubin.It clinically helps to treat neonatal jaundice.关键词
布拉氏酵母菌/新生儿黄疸/胆红素Key words
Saccharomyces boulardii/ Neonatal jaundice/ Nilirubin引用本文复制引用
洪绍虹,蔡勉珊,谢城..布拉氏酵母菌治疗新生儿黄疸的临床研究[J].国际医药卫生导报,2014,20(13):1957-1959,3.
